Radiographic Progression of Infiltrated Caries Lesions In-vivo
- Conditions
- Dental Caries
- Interventions
- Device: Resin infiltrationBehavioral: Caries management
- Registration Number
- NCT01496456
- Lead Sponsor
- University of Michigan
- Brief Summary
This study is investigating the efficacy of caries lesion infiltration therapy as compared to the current preventative approach for early caries lesions.
- Detailed Description
A 3-year longitudinal, prospective, randomized control clinical trial (RCT) is designed incorporating a split-mouth intra-oral design. Young volunteers (14-35 years old) with at least two early lesions in posterior teeth will be enrolled into this clinical trial to evaluate the clinical effectiveness of arresting lesion progression by infiltrating the lesions. The infiltration protocol included application of on-market materials and applicators, and was performed in one session.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17
- 14-35 year old subjects
- decayed-missing-filled permanent teeth (DMFT) ≥ 3
- having at least two early caries lesions in approximal posterior tooth surfaces
- lesion visible on radiograph
- Current participation in another clinical study
- Medically compromised subjects
- Hyposalivation
- Pregnancy
- Allergic to methylmethacrylates
- Allergic to latex
- Symptomatic teeth
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lesion infiltration Resin infiltration Resin infiltration of caries lesion in addition to caries management by preventative measures of oral hygiene instruction, diet counseling and fluoride supplementation Lesion infiltration Caries management Resin infiltration of caries lesion in addition to caries management by preventative measures of oral hygiene instruction, diet counseling and fluoride supplementation Preventative measures Caries management Caries management by preventative measures of oral hygiene instruction, diet counseling and fluoride supplementation
- Primary Outcome Measures
Name Time Method Number of Lesions Showing Radiographic Progression as Measured by Lesion Size (Continuous) Baseline through 3 years Pairwise radiographic assessment of lesion progression: combined visual assessment (PWA) and digital subtraction radiography (DSR).
- Secondary Outcome Measures
Name Time Method Number of Lesions Showing Radiographic Progression as Measured by Lesion Depth Categories Baseline through 3 years Radiographic assessment of lesion depth category (R1-R5) by single radiograph assessment (SRA).
Lesion Survival After 3 Years 3 years Discrete time survival analysis of time to first lesion progression.
Trial Locations
- Locations (1)
University of Toledo Medical Center
🇺🇸Toledo, Ohio, United States